Advertisement

Topics

CellAegis Announces First Distribution Agreement for autoRIC® in Europe

09:00 EDT 24 Apr 2018 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
TORONTO, April 24, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. ("CellAegis") a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective solutions for acute and chronic cardiovascular conditions...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "CellAegis Announces First Distribution Agreement for autoRIC® in Europe"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...